Vemurafenib in non-melanoma V600 and non-V600 BRAF mutated cancers: Results of the AcSe basket trial

被引：0

作者：

Tomasini, P. ^{[1
]}

Mazieres, J. ^{[2
]}

Cropet, C. ^{[3
]}

Troussard, X. G. ^{[4
]}

Malka, D.

Ray-Coquard, I. L. ^{[5
,6
]}

Leboulleux, S. ^{[7
]}

Flechon, A. ^{[8
]}

Arnulf, B. ^{[9
]}

Cancel, M. ^{[10
]}

Bieche, I. ^{[11
]}

Collot, S. ^{[12
]}

Taieb, S. ^{[13
]}

Garcia, G. ^{[14
]}

Mandache, A-M. ^{[15
]}

Colignon, N. ^{[16
]}

Gavrel, M. ^{[14
]}

Jimenez, M. ^{[17
]}

Hoog-Labouret, N. ^{[18
]}

Blay, J-Y. ^{[6
]}

机构：

[1] Aix Marseille Univ, AP HM, Dept Multidisciplinary Oncol & Therapeut Innovat, Marseille, France

[2] Toulouse Univ Hosp, Thorac Oncol Dept, Toulouse, France

[3] Ctr Leon Berard, Direct Rech Clin & Innovat DRCI, Lyon, France

[4] CHU Caen Normandie, Hematol, Caen, France

[5] Gustave Roussy, Digest Oncol Dept, Villejuif, France

[6] Ctr Leon Berard, Med Oncol, Lyon, France

[7] Gustave Roussy, Med Nucl & Endocrine Oncol, Villejuif, France

[8] Ctr Leon Berard, Dept Urol Oncol, Lyon, France

[9] Hosp St Louis, APHP, Hematol, Paris, France

[10] CHU Bretonneau, Med Oncol, Tours, France

[11] Paris Descartes Univ, Dept Genet, Inst Curie, Paris, France

[12] CHU Toulouse, Radiol & Med Imagery, Hop Rangueil Larrey, Toulouse, France

[13] Oscar Lambret, Med Imagery, Lille, France

[14] Gustave Roussy, Med Imagery, Villejuif, France

[15] Ctr Leon Berard, Med Imagery, Lyon, France

[16] Hop St Antoine, APHP, Radiol, Paris, France

[17] UNICANCER, R&D Dept, Paris, France

[18] Natl Canc Inst, Res & Innovat, Boulogne, France

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷

关键词：

D O I：

10.1016/j.annonc.2020.08.652

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

538P

引用

页码：S470 / S471

页数：2

共 50 条

[31] Efficacy and Safety of Trametinib in Non-V600 BRAF Mutant Melanoma: A Phase II Study
Nebhan, Caroline A.
Johnson, Douglas B.
Sullivan, Ryan J.
Amaria, Roda N.
Flaherty, Keith T.
Sosman, Jeffrey A.
Davies, Michael A.
[J]. ONCOLOGIST, 2021, 26 (09): : 731 - +
[32] Good response to targeted therapy in malignant melanoma with rare non-V600 BRAF mutation
Heinrich, C.
Rafei-Shamsabadi, D.
Meiss, F.
Brummer, T.
[J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 109 - 109
[33] Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
Flaherty, Keith T.
Infante, Jeffery R.
Daud, Adil
Gonzalez, Rene
Kefford, Richard F.
Sosman, Jeffrey
Hamid, Omid
Schuchter, Lynn
Cebon, Jonathan
Ibrahim, Nageatte
Kudchadkar, Ragini
Burris, Howard A., III
Falchook, Gerald
Algazi, Alain
Lewis, Karl
Long, Georgina V.
Puzanov, Igor
Lebowitz, Peter
Singh, Ajay
Little, Shonda
Sun, Peng
Allred, Alicia
Ouellet, Daniele
Kim, Kevin B.
Patel, Kiran
Weber, Jeffrey
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (18): : 1694 - 1703
[34] Vemurafenib in Melanoma with BRAF V600E Mutation
Dalle, Stephane
Poulalhon, Nicolas
Thomas, Luc
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (15): : 1448 - 1449
[35] BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
Del Bufalo, Francesca
Ceglie, Giulia
Cacchione, Antonella
Alessi, Iside
Colafati, Giovanna Stefania
Carai, Andrea
Diomedi-Camassei, Francesca
De Billy, Emmanuel
Agolini, Emanuele
Mastronuzzi, Angela
Locatelli, Franco
[J]. FRONTIERS IN ONCOLOGY, 2018, 8
[36] BRAF V600 mutations and pathological features in Japanese melanoma
Yamazaki, N.
Tanaka, R.
Tsutsumida, A.
Namikawa, K.
Eguchi, H.
Omata, W.
Oashi, K.
Tsuta, K.
[J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S874 - S874
[37] Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations (vol 373, pg 726, 2015)
不详
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (16): : 1585 - 1585
[38] Beyond BRAF V600: Characterizing the genomic landscape of non-BRAF V600 mutations and BRAF fusions in 121,221 in adult patients with cancer
Coleman, N.
Gouda, M. A.
Roszik, J.
Subbiah, V.
[J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S589 - S589
[39] The use of vemurafenib in Australian patients with unresectable or metastatic melanoma containing the V600 BRAF gene mutation
Brown, Michael P.
Long, Georgina V.
[J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 1 - 15
[40] Functional characterization of non-V600 BRAF mutations and their response to Trametinib (Tram
Sullivan, Ryan J.
Barbash, Zohar
Edelheit, Oded
Vidne, Michael
Sosman, Jeffrey Alan
Flaherty, Keith
Davies, Michael A.
Johnson, Douglas Buckner
Tarcic, Gabi
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)

← 1 2 3 4 5 →